Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial.
Kronborg TM, Schierwagen R, Trošt K, Gao Q, Moritz T, Bendtsen F, Gantzel RH, Andersen ML, Teisner AS, Grønbæk H, Hobolth L, Møller S, Trebicka J, Kimer N. Kronborg TM, et al. Among authors: trebicka j. Hepatol Commun. 2023 Dec 1;7(12):e0332. doi: 10.1097/HC9.0000000000000332. eCollection 2023 Dec 1. Hepatol Commun. 2023. PMID: 38051553 Free PMC article. Clinical Trial.
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats.
Klein S, Klösel J, Schierwagen R, Körner C, Granzow M, Huss S, Mazar IG, Weber S, van den Ven PF, Pieper-Fürst U, Fürst DO, Nattermann J, Lammert F, Sauerbruch T, Trebicka J. Klein S, et al. Among authors: trebicka j. Lab Invest. 2012 Oct;92(10):1440-50. doi: 10.1038/labinvest.2012.106. Epub 2012 Aug 13. Lab Invest. 2012. PMID: 22890553 Free article.
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, Wedemeyer I, Drebber U, Rockstroh J, Sauerbruch T, Dienes HP, Odenthal M. Trebicka J, et al. J Hepatol. 2013 Feb;58(2):234-9. doi: 10.1016/j.jhep.2012.10.015. Epub 2012 Oct 22. J Hepatol. 2013. PMID: 23085648
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P, Payer BA, Grahovac J, Klein S, Horvatits T, Mitterhauser M, Stift J, Boucher Y, Trebicka J, Trauner M, Angermayr B, Fuhrmann V, Reiberger T, Peck-Radosavljevic M. Schwabl P, et al. Among authors: trebicka j. J Hepatol. 2014 Jun;60(6):1135-42. doi: 10.1016/j.jhep.2014.01.025. Epub 2014 Feb 13. J Hepatol. 2014. PMID: 24530596
447 results